China IVD market hubChina IVD marketChina’s government is investing to build up the country’s in vitro diagnostics (IVD) testing capacity and meet strong clinical demand from an ageing population. With major policies, regulations and the growth of domestic players shaking up the country’s IVD market dynamics, companies are localising and adapting their strategies to stay ahead in this fast-evolving market. Clearstate offers market data, analysis and forecasts to give you the insight needed to capture opportunities in China, the world’s largest emerging IVD market. Our China IVD market hub is regularly updated to share our findings on this fast-evolving market. Inquire now
Tissue-based companion diagnostics market to grow for the most common cancers in ChinaCompanion diagnostics (CDx) use is growing as the cancer treatment paradigm-shifts towards immunotherapy and targeted therapy. Read more
Rise of connected blood glucose testing at Chinese hospitalsIn China, the use of connected point-of-care (POC) blood glucose testing will play an increasingly important role in diabetes management at hospitals. China has the largest number of diabetes cases in the world. Read more
Q2 2022 IVD China: point-of-care infectious-disease testing outperforms during the latest covid surgeThe impact of China’s latest covid-19 surge heads the latest quarterly in vitro diagnostics (IVD) market data. Read more
Quarterly Company InsightsQuarterly Company Insights (QCI) provides in-depth reports on China’s top IVD companies’ localised commercial activities in core labs, point-of-care testing, molecular and tissue diagnostics to help you understand the key players’ dynamics in the world’s largest emerging IVD market. Read more
IVD Size & Share PlusThe go-to source for tracking and understanding market size, share and trends in the global in vitro diagnostics market. Granular break-out of data and comprehensive coverage of international and domestic suppliers’ brand share across Asia, Europe, Latin America and the Middle East. Read more
LabPRO PlusLab by lab profiles of centralised diagnostics (CEDx) labs, molecular diagnostics labs (MDx) and tissue diagnostics (TDx) labs across hospitals and commercial settings to help your business understand current test, instrument and reagent usage of target customers. Read more
Clearstate newsletterSign up to our newsletter for insights into key market data, trends and developments across IVD and Surgical segments from our specialists and analysts. Sign up now